Vifor Pharma AG (GNHAY) Stock Analysis
DELISTED
What happened to Vifor Pharma AG (GNHAY) stock?
Vifor Pharma AG (GNHAY) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 7.80 means the share price is 7.80 times one year of earnings per share.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Vifor Pharma AG (GNHAY). Vifor Pharma AG, now a subsidiary of CSL Behring AG, specializes in the development, manufacturing, and commercialization of pharmaceutical products, primarily focusing on iron deficiency and nephrology.
Last analyzed: Mar 18, 2026Vifor Pharma AG (GNHAY) Healthcare & Pipeline Overview
Vifor Pharma AG ADR Information Unsponsored
Vifor Pharma AG (GNHAY) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: GNHA
GNHAY OTC Market Information
GNHAY trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy GNHAY shares?
No. GNHAY stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for GNHAY elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before GNHAY stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Vifor Pharma AG. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.